VKTX
Viking Therapeutics, Inc.$32.78-0.20 (-0.61%)Prev Close$32.98·MCap$3.80B·P/E—·Vol1.34M·Yield—
▲
Buys (12M)
1
$149.9K
▼
Sells (12M)
14
$28.80M
◆
Net Activity
Net Seller
$28.65M
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at Viking Therapeutics, Inc. (VKTX) has been dominated by selling, with 1 insider purchase totaling $149.9K and 14 insider sales totaling $28.80M. The most recent insider transaction was by Aubuchon Neil William (officer: Chief Commercial Officer), who purchased $149.9K worth of shares on Mar 10, 2026. Viking Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $3.80B.
VKTX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Aubuchon Neil William | officer: Chief Commercial Officer | Buy | 4,475 | $33.50 | $149.9K | 4,475 |
| Jan 5, 2026 | FOEHR MATTHEW W | director | Sell | 16,000 | $35.11 | $561.7K | 132,036 |
| Jan 5, 2026 | Lian Brian | director, officer: President & CEO | Sell | 233,409 | $32.96 | $7.69M | 2,600,246 |
| Jan 5, 2026 | Mancini Marianna | officer: Chief Operating Officer | Sell | 57,661 | $32.98 | $1.90M | 434,890 |
| Jan 5, 2026 | ZANTE GREG | officer: Chief Financial Officer | Sell | 57,661 | $32.90 | $1.90M | 215,571 |
| Jan 2, 2026 | FOEHR MATTHEW W | Director | Sell | 16,000 | $35.11 | $561.7K | 0 |
| Jan 2, 2026 | Lian Brian | President & CEO | Sell | 233,409 | $32.96 | $7.69M | 0 |
| Jan 2, 2026 | Mancini Marianna | Chief Operating Officer | Sell | 57,661 | $32.98 | $1.90M | 0 |
| Jan 2, 2026 | ZANTE GREG | Chief Financial Officer | Sell | 57,661 | $32.90 | $1.90M | 0 |
| Oct 27, 2025 | Lian Brian | President & CEO | Sell | 38,989 | $35.01 | $1.36M | 0 |
| Oct 27, 2025 | Mancini Marianna | Chief Operating Officer | Sell | 6,185 | $35.00 | $216.5K | 0 |
| Oct 27, 2025 | Rowland Charles A Jr | Director | Sell | 60,000 | $35.57 | $2.13M | 0 |
| Jul 2, 2025 | Lian Brian | President & CEO | Sell | 26,889 | $27.80 | $747.6K | 0 |
| Jul 2, 2025 | Mancini Marianna | Chief Operating Officer | Sell | 4,266 | $27.77 | $118.5K | 0 |
| Jul 2, 2025 | ZANTE GREG | Chief Financial Officer | Sell | 4,266 | $27.76 | $118.4K | 0 |
| Mar 31, 2025 | Rouan Sarah Kathryn | Director | Buy | 1,240 | $24.15 | $29.9K | 0 |
| Jan 6, 2025 | Lian Brian | President & CEO | Sell | 194,490 | $42.75 | $8.31M | 2,385,570 |
| Jan 6, 2025 | Mancini Marianna | Chief Operating Officer | Sell | 54,215 | $42.75 | $2.32M | 379,234 |
| Jan 6, 2025 | ZANTE GREG | Chief Financial Officer | Sell | 50,309 | $42.75 | $2.15M | 169,959 |
| Nov 8, 2024 | MACARTNEY LAWSON | Sell | 2,000 | $68.67 | $137.3K | 47,965 | |
| Oct 28, 2024 | ZANTE GREG | Chief Financial Officer | Sell | 131,687 | $76.62 | $10.09M | 231,381-36% |
| Oct 25, 2024 | Rouan Sarah Kathryn | Sell | 11,000 | $80.89 | $889.8K | 0Exit | |
| Oct 25, 2024 | SINGLETON J MATTHEW | Sell | 16,000 | $79.50 | $1.27M | 9,500-63% | |
| Sep 20, 2024 | Lian Brian | President & CEO | Sell | 216,130 | $70.83 | $15.31M | 2,425,001 |
| Sep 20, 2024 | SINGLETON J MATTHEW | Sell | 10,300 | $69.50 | $715.9K | 9,500-52% | |
| Aug 22, 2024 | Lian Brian | President & CEO | Sell | 1,000 | $69.90 | $69.9K | 2,354,927 |
| Aug 22, 2024 | SINGLETON J MATTHEW | Sell | 5,700 | $69.72 | $397.4K | 9,500-38% | |
| Aug 19, 2024 | Lian Brian | President & CEO | Sell | 112,870 | $65.80 | $7.43M | 2,397,665 |
| Aug 19, 2024 | SINGLETON J MATTHEW | Sell | 16,000 | $62.22 | $995.5K | 23,000-41% | |
| Aug 14, 2024 | SINGLETON J MATTHEW | Sell | 20,786 | $57.53 | $1.20M | 9,660-68% | |
| Jul 31, 2024 | Lian Brian | President & CEO | Sell | 115,859 | $57.58 | $6.67M | 2,404,845 |
| Jul 31, 2024 | Mancini Marianna | Chief Operating Officer | Sell | 18,026 | $57.13 | $1.03M | 365,471 |
| Jul 31, 2024 | ZANTE GREG | Chief Financial Officer | Sell | 16,136 | $57.15 | $922.2K | 190,526 |
| May 3, 2024 | ZANTE GREG | Chief Financial Officer | Sell | 66,756 | $74.69 | $4.99M | 238,509 |
| May 2, 2024 | Mancini Marianna | Chief Operating Officer | Sell | 281,425 | $78.66 | $22.14M | 606,187-32% |
| Feb 9, 2024 | Lian Brian | President & CEO | Sell | 45,000 | $29.90 | $1.35M | 2,139,882 |
| Feb 8, 2024 | Lian Brian | President & CEO | Sell | 269,079 | $26.87 | $7.23M | 2,344,882 |
| Feb 8, 2024 | Rouan Sarah Kathryn | Director | Sell | 25,000 | $28.05 | $701.3K | 0Exit |
| Jan 31, 2024 | Lian Brian | President & CEO | Sell | 85,000 | $24.71 | $2.10M | 2,309,882 |
| Jan 30, 2024 | Lian Brian | President & CEO | Sell | 35,000 | $23.95 | $838.3K | 2,264,882 |
| Jan 19, 2024 | Rouan Sarah Kathryn | Director | Sell | 30,000 | $23.05 | $691.5K | 0Exit |
| Jan 4, 2024 | ZANTE GREG | Chief Financial Officer | Sell | 15,000 | $17.90 | $268.5K | 180,730 |
| May 18, 2023 | MACARTNEY LAWSON | Director | Sell | 16,000 | $24.00 | $384.0K | 47,965-25% |
| May 18, 2023 | Rowland Charles A Jr | Director | Sell | 40,000 | $25.00 | $1.00M | 30,000-57% |
| May 1, 2023 | Lian Brian | President & CEO | Sell | 45,000 | $22.45 | $1.01M | 2,197,963 |
| Apr 24, 2023 | MACARTNEY LAWSON | Director | Sell | 16,000 | $22.00 | $352.1K | 47,965-25% |
| Apr 21, 2023 | Lian Brian | President & CEO | Sell | 35,000 | $21.45 | $750.8K | 2,242,963 |
| Apr 18, 2023 | Lian Brian | President & CEO | Sell | 155,000 | $20.45 | $3.17M | 2,277,963 |
| Apr 18, 2023 | MACARTNEY LAWSON | Director | Sell | 20,786 | $20.00 | $415.7K | 47,965-30% |
| Apr 18, 2023 | Mancini Marianna | Chief Operating Officer | Sell | 12,500 | $20.00 | $250.0K | 287,763 |
Showing 1–50 of 58
1 / 2
VKTX Insider Buying Activity
The following table shows recent insider purchases of Viking Therapeutics, Inc. (VKTX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Aubuchon Neil William | officer: Chief Commercial Officer | Buy | 4,475 | $33.50 | $149.9K | 4,475 |
| Mar 31, 2025 | Rouan Sarah Kathryn | Director | Buy | 1,240 | $24.15 | $29.9K | 0 |
VKTX Insider Selling Activity
The following table shows recent insider sales of Viking Therapeutics, Inc. (VKTX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | FOEHR MATTHEW W | director | Sell | 16,000 | $35.11 | $561.7K | 132,036 |
| Jan 5, 2026 | Lian Brian | director, officer: President & CEO | Sell | 233,409 | $32.96 | $7.69M | 2,600,246 |
| Jan 5, 2026 | Mancini Marianna | officer: Chief Operating Officer | Sell | 57,661 | $32.98 | $1.90M | 434,890 |
| Jan 5, 2026 | ZANTE GREG | officer: Chief Financial Officer | Sell | 57,661 | $32.90 | $1.90M | 215,571 |
| Jan 2, 2026 | FOEHR MATTHEW W | Director | Sell | 16,000 | $35.11 | $561.7K | 0 |
| Jan 2, 2026 | Lian Brian | President & CEO | Sell | 233,409 | $32.96 | $7.69M | 0 |
| Jan 2, 2026 | Mancini Marianna | Chief Operating Officer | Sell | 57,661 | $32.98 | $1.90M | 0 |
| Jan 2, 2026 | ZANTE GREG | Chief Financial Officer | Sell | 57,661 | $32.90 | $1.90M | 0 |
| Oct 27, 2025 | Lian Brian | President & CEO | Sell | 38,989 | $35.01 | $1.36M | 0 |
| Oct 27, 2025 | Mancini Marianna | Chief Operating Officer | Sell | 6,185 | $35.00 | $216.5K | 0 |
| Oct 27, 2025 | Rowland Charles A Jr | Director | Sell | 60,000 | $35.57 | $2.13M | 0 |
| Jul 2, 2025 | Lian Brian | President & CEO | Sell | 26,889 | $27.80 | $747.6K | 0 |
| Jul 2, 2025 | Mancini Marianna | Chief Operating Officer | Sell | 4,266 | $27.77 | $118.5K | 0 |
| Jul 2, 2025 | ZANTE GREG | Chief Financial Officer | Sell | 4,266 | $27.76 | $118.4K | 0 |
| Jan 6, 2025 | Lian Brian | President & CEO | Sell | 194,490 | $42.75 | $8.31M | 2,385,570 |
| Jan 6, 2025 | Mancini Marianna | Chief Operating Officer | Sell | 54,215 | $42.75 | $2.32M | 379,234 |
| Jan 6, 2025 | ZANTE GREG | Chief Financial Officer | Sell | 50,309 | $42.75 | $2.15M | 169,959 |
| Nov 8, 2024 | MACARTNEY LAWSON | Sell | 2,000 | $68.67 | $137.3K | 47,965 | |
| Oct 28, 2024 | ZANTE GREG | Chief Financial Officer | Sell | 131,687 | $76.62 | $10.09M | 231,381-36% |
| Oct 25, 2024 | Rouan Sarah Kathryn | Sell | 11,000 | $80.89 | $889.8K | 0Exit | |
| Oct 25, 2024 | SINGLETON J MATTHEW | Sell | 16,000 | $79.50 | $1.27M | 9,500-63% | |
| Sep 20, 2024 | Lian Brian | President & CEO | Sell | 216,130 | $70.83 | $15.31M | 2,425,001 |
| Sep 20, 2024 | SINGLETON J MATTHEW | Sell | 10,300 | $69.50 | $715.9K | 9,500-52% | |
| Aug 22, 2024 | Lian Brian | President & CEO | Sell | 1,000 | $69.90 | $69.9K | 2,354,927 |
| Aug 22, 2024 | SINGLETON J MATTHEW | Sell | 5,700 | $69.72 | $397.4K | 9,500-38% | |
| Aug 19, 2024 | Lian Brian | President & CEO | Sell | 112,870 | $65.80 | $7.43M | 2,397,665 |
| Aug 19, 2024 | SINGLETON J MATTHEW | Sell | 16,000 | $62.22 | $995.5K | 23,000-41% | |
| Aug 14, 2024 | SINGLETON J MATTHEW | Sell | 20,786 | $57.53 | $1.20M | 9,660-68% | |
| Jul 31, 2024 | Lian Brian | President & CEO | Sell | 115,859 | $57.58 | $6.67M | 2,404,845 |
| Jul 31, 2024 | Mancini Marianna | Chief Operating Officer | Sell | 18,026 | $57.13 | $1.03M | 365,471 |
| Jul 31, 2024 | ZANTE GREG | Chief Financial Officer | Sell | 16,136 | $57.15 | $922.2K | 190,526 |
| May 3, 2024 | ZANTE GREG | Chief Financial Officer | Sell | 66,756 | $74.69 | $4.99M | 238,509 |
| May 2, 2024 | Mancini Marianna | Chief Operating Officer | Sell | 281,425 | $78.66 | $22.14M | 606,187-32% |
| Feb 9, 2024 | Lian Brian | President & CEO | Sell | 45,000 | $29.90 | $1.35M | 2,139,882 |
| Feb 8, 2024 | Lian Brian | President & CEO | Sell | 269,079 | $26.87 | $7.23M | 2,344,882 |
| Feb 8, 2024 | Rouan Sarah Kathryn | Director | Sell | 25,000 | $28.05 | $701.3K | 0Exit |
| Jan 31, 2024 | Lian Brian | President & CEO | Sell | 85,000 | $24.71 | $2.10M | 2,309,882 |
| Jan 30, 2024 | Lian Brian | President & CEO | Sell | 35,000 | $23.95 | $838.3K | 2,264,882 |
| Jan 19, 2024 | Rouan Sarah Kathryn | Director | Sell | 30,000 | $23.05 | $691.5K | 0Exit |
| Jan 4, 2024 | ZANTE GREG | Chief Financial Officer | Sell | 15,000 | $17.90 | $268.5K | 180,730 |
| May 18, 2023 | MACARTNEY LAWSON | Director | Sell | 16,000 | $24.00 | $384.0K | 47,965-25% |
| May 18, 2023 | Rowland Charles A Jr | Director | Sell | 40,000 | $25.00 | $1.00M | 30,000-57% |
| May 1, 2023 | Lian Brian | President & CEO | Sell | 45,000 | $22.45 | $1.01M | 2,197,963 |
| Apr 24, 2023 | MACARTNEY LAWSON | Director | Sell | 16,000 | $22.00 | $352.1K | 47,965-25% |
| Apr 21, 2023 | Lian Brian | President & CEO | Sell | 35,000 | $21.45 | $750.8K | 2,242,963 |
| Apr 18, 2023 | Lian Brian | President & CEO | Sell | 155,000 | $20.45 | $3.17M | 2,277,963 |
| Apr 18, 2023 | MACARTNEY LAWSON | Director | Sell | 20,786 | $20.00 | $415.7K | 47,965-30% |
| Apr 18, 2023 | Mancini Marianna | Chief Operating Officer | Sell | 12,500 | $20.00 | $250.0K | 287,763 |
VKTX Insiders
Similar Stocks to VKTX
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B